Abstract
Background Sex differences in systolic blood pressure (SBP) emerge during adolescence but the role of puberty is not well understood. We examined sex-specific changes in SBP preceding and following puberty and examined the impact of puberty timing on SBP trajectories in females and males.
Methods Trajectories of SBP before and after puberty and by timing of puberty in females and males in a contemporary English birth cohort study were analysed. Repeated measures of height from age 5 to 20 years were used to identify puberty timing (age at peak height velocity). SBP was measured on ten occasions from 3 to 24 years (N participants=4,062, repeated SBP measures=29,172). Analyses were preformed using linear spline multilevel models based on time before and after puberty and were adjusted for parental factors and early childhood factors including BMI gain from age one up to 9 years.
Results Mean age at peak height velocity was 11.7 years (standard deviation (SD) =0.8) for females and 13.6 years (SD=0.9) for males. In adjusted models, females and males had similar SBP at age 3. Males had faster rates of increase in SBP before puberty leading to 10.19mmHg (95% CI: 6.80, 13.57) higher mean SBP at puberty which remained similar at 24 years [mean difference; 11.43mmHg (95% CI: 7.22, 15.63)]. Puberty timing was associated with small transient differences in SBP trajectories post-puberty in both sexes and small differences at 24 years in females only.
Conclusion A large proportion of the higher SBP observed in males compared to females in early adulthood is accrued before puberty. Prevention of high SBP in adult males may therefore benefit from a life course approach starting from before puberty. Interventions targeting puberty timing are unlikely to greatly influence SBP in females and males in early adulthood.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The UK Medical Research Council and Wellcome (grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf); this research was specifically funded Wellcome Trust and MRC (grant ref: 076467/Z/05/Z and 086676/Z/08/Z). KON is supported by a Health Research Board (HRB) of Ireland Emerging Investigator Award (EIA-FA-2019-007 SCaRLeT). LMOK is also supported by the HRB Emerging Investigator Award (EIA-FA-2019-007 SCaRLeT) and a UK Medical Research Council Population Health Scientist fellowship (MR/M014509/1). JAB is supported by the Elizabeth Blackwell Institute for Health Research, University of Bristol and the Wellcome Trust Institutional Strategic Support Fund (204813/Z/16/Z). GDS and KT work in a unit funded by the UK MRC (MC_UU_00011/1 and MC UU 00011/3) and the University of Bristol. These funding sources had no role in the design and conduct of this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
ALSPAC Ethics and Law Committee and the Local Research Ethics Committees
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Individual-level ALSPAC data are available following an application. This process of managed access is detailed at www.bristol.ac.uk/alspac/researchers/access. Cohort details and data descriptions for ALSPAC are publicly available at the same web address.
